Metabolic requirements for neutrophil extracellular traps formation

Summary As part of the innate immune response, neutrophils are at the forefront of defence against infection, resolution of inflammation and wound healing. They are the most abundant leucocytes in the peripheral blood, have a short lifespan and an estimated turnover of 1010 to 1011 cells per day. Ne...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunology 2015-06, Vol.145 (2), p.213-224
Hauptverfasser: Rodríguez‐Espinosa, Oscar, Rojas‐Espinosa, Oscar, Moreno‐Altamirano, María Maximina Bertha, López‐Villegas, Edgar Oliver, Sánchez‐García, Francisco Javier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 224
container_issue 2
container_start_page 213
container_title Immunology
container_volume 145
creator Rodríguez‐Espinosa, Oscar
Rojas‐Espinosa, Oscar
Moreno‐Altamirano, María Maximina Bertha
López‐Villegas, Edgar Oliver
Sánchez‐García, Francisco Javier
description Summary As part of the innate immune response, neutrophils are at the forefront of defence against infection, resolution of inflammation and wound healing. They are the most abundant leucocytes in the peripheral blood, have a short lifespan and an estimated turnover of 1010 to 1011 cells per day. Neutrophils efficiently clear microbial infections by phagocytosis and by oxygen‐dependent and oxygen‐independent mechanisms. In 2004, a new neutrophil anti‐microbial mechanism was described, the release of neutrophil extracellular traps (NETs) composed of DNA, histones and anti‐microbial peptides. Several microorganisms, bacterial products, as well as pharmacological stimuli such as PMA, were shown to induce NETs. Neutrophils contain relatively few mitochondria, and derive most of their energy from glycolysis. In this scenario we aimed to analyse some of the metabolic requirements for NET formation. Here it is shown that NETs formation is strictly dependent on glucose and to a lesser extent on glutamine, that Glut‐1, glucose uptake, and glycolysis rate increase upon PMA stimulation, and that NET formation is inhibited by the glycolysis inhibitor, 2‐deoxy‐glucose, and to a lesser extent by the ATP synthase inhibitor oligomycin. Moreover, when neutrophils were exposed to PMA in glucose‐free medium for 3 hr, they lost their characteristic polymorphic nuclei but did not release NETs. However, if glucose (but not pyruvate) was added at this time, NET release took place within minutes, suggesting that NET formation could be metabolically divided into two phases; the first, independent from exogenous glucose (chromatin decondensation) and, the second (NET release), strictly dependent on exogenous glucose and glycolysis.
doi_str_mv 10.1111/imm.12437
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4427386</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1680179538</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5097-5e1f479550adc74c2de83563520e870b1f91b4a9d91f22dc258443cbc3d45ee33</originalsourceid><addsrcrecordid>eNp1kctKxDAUhoMoOl4WvoAU3OiimmvTbAQZvIGDG12HND3VSNuMSavO2xsdFRXMJjnk4-M__AjtEnxE0jl2XXdEKGdyBU0IK0RORSFX0QRjonJaYrGBNmN8TCPDQqyjDSoEF5TKCZrOYDCVb53NAjyNLkAH_RCzxoesh3EIfv7g2gxeh2AstO3YmpCl9_wD6czgfL-N1hrTRtj5vLfQ3fnZ7fQyv765uJqeXudWYCVzAaThUgmBTW0lt7SGkomCCYqhlLgijSIVN6pWpKG0tlSUnDNbWVZzAcDYFjpZeudj1UFtU9BgWj0PrjNhob1x-vdP7x70vX_WnFPJyiIJDj4FwT-NEAfdufi-lenBj1GTosQkJWRlQvf_oI9-DH1aL1FSEUW4Uok6XFI2-BgDNN9hCNbv1ehUjf6oJrF7P9N_k19dJOB4Cby4Fhb_m_TVbLZUvgHNopk2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1679191499</pqid></control><display><type>article</type><title>Metabolic requirements for neutrophil extracellular traps formation</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Rodríguez‐Espinosa, Oscar ; Rojas‐Espinosa, Oscar ; Moreno‐Altamirano, María Maximina Bertha ; López‐Villegas, Edgar Oliver ; Sánchez‐García, Francisco Javier</creator><creatorcontrib>Rodríguez‐Espinosa, Oscar ; Rojas‐Espinosa, Oscar ; Moreno‐Altamirano, María Maximina Bertha ; López‐Villegas, Edgar Oliver ; Sánchez‐García, Francisco Javier</creatorcontrib><description>Summary As part of the innate immune response, neutrophils are at the forefront of defence against infection, resolution of inflammation and wound healing. They are the most abundant leucocytes in the peripheral blood, have a short lifespan and an estimated turnover of 1010 to 1011 cells per day. Neutrophils efficiently clear microbial infections by phagocytosis and by oxygen‐dependent and oxygen‐independent mechanisms. In 2004, a new neutrophil anti‐microbial mechanism was described, the release of neutrophil extracellular traps (NETs) composed of DNA, histones and anti‐microbial peptides. Several microorganisms, bacterial products, as well as pharmacological stimuli such as PMA, were shown to induce NETs. Neutrophils contain relatively few mitochondria, and derive most of their energy from glycolysis. In this scenario we aimed to analyse some of the metabolic requirements for NET formation. Here it is shown that NETs formation is strictly dependent on glucose and to a lesser extent on glutamine, that Glut‐1, glucose uptake, and glycolysis rate increase upon PMA stimulation, and that NET formation is inhibited by the glycolysis inhibitor, 2‐deoxy‐glucose, and to a lesser extent by the ATP synthase inhibitor oligomycin. Moreover, when neutrophils were exposed to PMA in glucose‐free medium for 3 hr, they lost their characteristic polymorphic nuclei but did not release NETs. However, if glucose (but not pyruvate) was added at this time, NET release took place within minutes, suggesting that NET formation could be metabolically divided into two phases; the first, independent from exogenous glucose (chromatin decondensation) and, the second (NET release), strictly dependent on exogenous glucose and glycolysis.</description><identifier>ISSN: 0019-2805</identifier><identifier>EISSN: 1365-2567</identifier><identifier>DOI: 10.1111/imm.12437</identifier><identifier>PMID: 25545227</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>ATP synthase ; Carcinogens - pharmacology ; cell metabolism ; Deoxyglucose - pharmacology ; Enzyme Inhibitors - pharmacology ; Extracellular Traps - immunology ; Extracellular Traps - metabolism ; Glucose - immunology ; Glucose - metabolism ; Glucose Transporter Type 1 - immunology ; Glucose Transporter Type 1 - metabolism ; Glutamine - immunology ; Glutamine - metabolism ; glycolysis ; Glycolysis - drug effects ; Humans ; neutrophil extracellular traps ; neutrophils ; Neutrophils - immunology ; Neutrophils - metabolism ; Original ; Tetradecanoylphorbol Acetate - pharmacology</subject><ispartof>Immunology, 2015-06, Vol.145 (2), p.213-224</ispartof><rights>2014 John Wiley &amp; Sons Ltd</rights><rights>2014 John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2015 John Wiley &amp; Sons Ltd</rights><rights>2014 John Wiley &amp; Sons Ltd 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5097-5e1f479550adc74c2de83563520e870b1f91b4a9d91f22dc258443cbc3d45ee33</citedby><cites>FETCH-LOGICAL-c5097-5e1f479550adc74c2de83563520e870b1f91b4a9d91f22dc258443cbc3d45ee33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427386/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427386/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,1427,27901,27902,45550,45551,46384,46808,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25545227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodríguez‐Espinosa, Oscar</creatorcontrib><creatorcontrib>Rojas‐Espinosa, Oscar</creatorcontrib><creatorcontrib>Moreno‐Altamirano, María Maximina Bertha</creatorcontrib><creatorcontrib>López‐Villegas, Edgar Oliver</creatorcontrib><creatorcontrib>Sánchez‐García, Francisco Javier</creatorcontrib><title>Metabolic requirements for neutrophil extracellular traps formation</title><title>Immunology</title><addtitle>Immunology</addtitle><description>Summary As part of the innate immune response, neutrophils are at the forefront of defence against infection, resolution of inflammation and wound healing. They are the most abundant leucocytes in the peripheral blood, have a short lifespan and an estimated turnover of 1010 to 1011 cells per day. Neutrophils efficiently clear microbial infections by phagocytosis and by oxygen‐dependent and oxygen‐independent mechanisms. In 2004, a new neutrophil anti‐microbial mechanism was described, the release of neutrophil extracellular traps (NETs) composed of DNA, histones and anti‐microbial peptides. Several microorganisms, bacterial products, as well as pharmacological stimuli such as PMA, were shown to induce NETs. Neutrophils contain relatively few mitochondria, and derive most of their energy from glycolysis. In this scenario we aimed to analyse some of the metabolic requirements for NET formation. Here it is shown that NETs formation is strictly dependent on glucose and to a lesser extent on glutamine, that Glut‐1, glucose uptake, and glycolysis rate increase upon PMA stimulation, and that NET formation is inhibited by the glycolysis inhibitor, 2‐deoxy‐glucose, and to a lesser extent by the ATP synthase inhibitor oligomycin. Moreover, when neutrophils were exposed to PMA in glucose‐free medium for 3 hr, they lost their characteristic polymorphic nuclei but did not release NETs. However, if glucose (but not pyruvate) was added at this time, NET release took place within minutes, suggesting that NET formation could be metabolically divided into two phases; the first, independent from exogenous glucose (chromatin decondensation) and, the second (NET release), strictly dependent on exogenous glucose and glycolysis.</description><subject>ATP synthase</subject><subject>Carcinogens - pharmacology</subject><subject>cell metabolism</subject><subject>Deoxyglucose - pharmacology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Extracellular Traps - immunology</subject><subject>Extracellular Traps - metabolism</subject><subject>Glucose - immunology</subject><subject>Glucose - metabolism</subject><subject>Glucose Transporter Type 1 - immunology</subject><subject>Glucose Transporter Type 1 - metabolism</subject><subject>Glutamine - immunology</subject><subject>Glutamine - metabolism</subject><subject>glycolysis</subject><subject>Glycolysis - drug effects</subject><subject>Humans</subject><subject>neutrophil extracellular traps</subject><subject>neutrophils</subject><subject>Neutrophils - immunology</subject><subject>Neutrophils - metabolism</subject><subject>Original</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><issn>0019-2805</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctKxDAUhoMoOl4WvoAU3OiimmvTbAQZvIGDG12HND3VSNuMSavO2xsdFRXMJjnk4-M__AjtEnxE0jl2XXdEKGdyBU0IK0RORSFX0QRjonJaYrGBNmN8TCPDQqyjDSoEF5TKCZrOYDCVb53NAjyNLkAH_RCzxoesh3EIfv7g2gxeh2AstO3YmpCl9_wD6czgfL-N1hrTRtj5vLfQ3fnZ7fQyv765uJqeXudWYCVzAaThUgmBTW0lt7SGkomCCYqhlLgijSIVN6pWpKG0tlSUnDNbWVZzAcDYFjpZeudj1UFtU9BgWj0PrjNhob1x-vdP7x70vX_WnFPJyiIJDj4FwT-NEAfdufi-lenBj1GTosQkJWRlQvf_oI9-DH1aL1FSEUW4Uok6XFI2-BgDNN9hCNbv1ehUjf6oJrF7P9N_k19dJOB4Cby4Fhb_m_TVbLZUvgHNopk2</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Rodríguez‐Espinosa, Oscar</creator><creator>Rojas‐Espinosa, Oscar</creator><creator>Moreno‐Altamirano, María Maximina Bertha</creator><creator>López‐Villegas, Edgar Oliver</creator><creator>Sánchez‐García, Francisco Javier</creator><general>Wiley Subscription Services, Inc</general><general>BlackWell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QR</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201506</creationdate><title>Metabolic requirements for neutrophil extracellular traps formation</title><author>Rodríguez‐Espinosa, Oscar ; Rojas‐Espinosa, Oscar ; Moreno‐Altamirano, María Maximina Bertha ; López‐Villegas, Edgar Oliver ; Sánchez‐García, Francisco Javier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5097-5e1f479550adc74c2de83563520e870b1f91b4a9d91f22dc258443cbc3d45ee33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>ATP synthase</topic><topic>Carcinogens - pharmacology</topic><topic>cell metabolism</topic><topic>Deoxyglucose - pharmacology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Extracellular Traps - immunology</topic><topic>Extracellular Traps - metabolism</topic><topic>Glucose - immunology</topic><topic>Glucose - metabolism</topic><topic>Glucose Transporter Type 1 - immunology</topic><topic>Glucose Transporter Type 1 - metabolism</topic><topic>Glutamine - immunology</topic><topic>Glutamine - metabolism</topic><topic>glycolysis</topic><topic>Glycolysis - drug effects</topic><topic>Humans</topic><topic>neutrophil extracellular traps</topic><topic>neutrophils</topic><topic>Neutrophils - immunology</topic><topic>Neutrophils - metabolism</topic><topic>Original</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodríguez‐Espinosa, Oscar</creatorcontrib><creatorcontrib>Rojas‐Espinosa, Oscar</creatorcontrib><creatorcontrib>Moreno‐Altamirano, María Maximina Bertha</creatorcontrib><creatorcontrib>López‐Villegas, Edgar Oliver</creatorcontrib><creatorcontrib>Sánchez‐García, Francisco Javier</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodríguez‐Espinosa, Oscar</au><au>Rojas‐Espinosa, Oscar</au><au>Moreno‐Altamirano, María Maximina Bertha</au><au>López‐Villegas, Edgar Oliver</au><au>Sánchez‐García, Francisco Javier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic requirements for neutrophil extracellular traps formation</atitle><jtitle>Immunology</jtitle><addtitle>Immunology</addtitle><date>2015-06</date><risdate>2015</risdate><volume>145</volume><issue>2</issue><spage>213</spage><epage>224</epage><pages>213-224</pages><issn>0019-2805</issn><eissn>1365-2567</eissn><abstract>Summary As part of the innate immune response, neutrophils are at the forefront of defence against infection, resolution of inflammation and wound healing. They are the most abundant leucocytes in the peripheral blood, have a short lifespan and an estimated turnover of 1010 to 1011 cells per day. Neutrophils efficiently clear microbial infections by phagocytosis and by oxygen‐dependent and oxygen‐independent mechanisms. In 2004, a new neutrophil anti‐microbial mechanism was described, the release of neutrophil extracellular traps (NETs) composed of DNA, histones and anti‐microbial peptides. Several microorganisms, bacterial products, as well as pharmacological stimuli such as PMA, were shown to induce NETs. Neutrophils contain relatively few mitochondria, and derive most of their energy from glycolysis. In this scenario we aimed to analyse some of the metabolic requirements for NET formation. Here it is shown that NETs formation is strictly dependent on glucose and to a lesser extent on glutamine, that Glut‐1, glucose uptake, and glycolysis rate increase upon PMA stimulation, and that NET formation is inhibited by the glycolysis inhibitor, 2‐deoxy‐glucose, and to a lesser extent by the ATP synthase inhibitor oligomycin. Moreover, when neutrophils were exposed to PMA in glucose‐free medium for 3 hr, they lost their characteristic polymorphic nuclei but did not release NETs. However, if glucose (but not pyruvate) was added at this time, NET release took place within minutes, suggesting that NET formation could be metabolically divided into two phases; the first, independent from exogenous glucose (chromatin decondensation) and, the second (NET release), strictly dependent on exogenous glucose and glycolysis.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>25545227</pmid><doi>10.1111/imm.12437</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0019-2805
ispartof Immunology, 2015-06, Vol.145 (2), p.213-224
issn 0019-2805
1365-2567
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4427386
source Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects ATP synthase
Carcinogens - pharmacology
cell metabolism
Deoxyglucose - pharmacology
Enzyme Inhibitors - pharmacology
Extracellular Traps - immunology
Extracellular Traps - metabolism
Glucose - immunology
Glucose - metabolism
Glucose Transporter Type 1 - immunology
Glucose Transporter Type 1 - metabolism
Glutamine - immunology
Glutamine - metabolism
glycolysis
Glycolysis - drug effects
Humans
neutrophil extracellular traps
neutrophils
Neutrophils - immunology
Neutrophils - metabolism
Original
Tetradecanoylphorbol Acetate - pharmacology
title Metabolic requirements for neutrophil extracellular traps formation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T12%3A24%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20requirements%20for%20neutrophil%20extracellular%20traps%20formation&rft.jtitle=Immunology&rft.au=Rodr%C3%ADguez%E2%80%90Espinosa,%20Oscar&rft.date=2015-06&rft.volume=145&rft.issue=2&rft.spage=213&rft.epage=224&rft.pages=213-224&rft.issn=0019-2805&rft.eissn=1365-2567&rft_id=info:doi/10.1111/imm.12437&rft_dat=%3Cproquest_pubme%3E1680179538%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1679191499&rft_id=info:pmid/25545227&rfr_iscdi=true